145 related articles for article (PubMed ID: 6173312)
1. Activation of the alternative complement pathway of guinea-gip by liposomes incorporated with trinitrophenylated phosphatidylethanolamine.
Okada N; Yasuda T; Tsumita T; Okada H
Immunology; 1982 Jan; 45(1):115-24. PubMed ID: 6173312
[TBL] [Abstract][Full Text] [Related]
2. Differing reactivities of human and guinea-pig complement on haptenized liposomes via the alternative pathway.
Okada N; Yasuda T; Tsumita T; Okada H
Mol Immunol; 1983 Aug; 20(8):857-64. PubMed ID: 6194429
[TBL] [Abstract][Full Text] [Related]
3. Activation of the alternative complement pathway by natural antibody to glycolipids in guinea-pig serum.
Okada N; Yasuda T; Tsumita T; Okada H
Immunology; 1983 Sep; 50(1):75-84. PubMed ID: 6193057
[TBL] [Abstract][Full Text] [Related]
4. Membrane sialoglycolipids regulate the activation of alternative complement pathway by liposomes containing trinitrophenylaminocaproyldipalmitoylphosphatidylethaolamine.
Okada N; Yasuda T; Tsumita T; Okada H
Immunology; 1983 Jan; 48(1):129-40. PubMed ID: 6848448
[TBL] [Abstract][Full Text] [Related]
5. Activation of the alternative complement pathway by IgM antibody reacted on paragloboside incorporated into liposome membrane.
Okada H; Okada N; Yasuda T
Mol Immunol; 1983 Apr; 20(4):499-500. PubMed ID: 6865961
[TBL] [Abstract][Full Text] [Related]
6. Hemolysis by the complement of tanned erythrocytes coated with cobra venom factor: a sensitive method to detect the alternative complement pathway activity of serum.
Okada H; Tanaka H
J Immunol Methods; 1981; 46(1):85-95. PubMed ID: 6793665
[TBL] [Abstract][Full Text] [Related]
7. Alternative complement pathway activation by C4b deposited during classical pathway activation.
Matsushita M; Okada H
J Immunol; 1986 Apr; 136(8):2994-8. PubMed ID: 2937839
[TBL] [Abstract][Full Text] [Related]
8. Effect of membrane phospholipids on activation of the alternative complement pathway.
Mold C
J Immunol; 1989 Sep; 143(5):1663-8. PubMed ID: 2527270
[TBL] [Abstract][Full Text] [Related]
9. The role of surface charge in the activation of the classical and alternative pathways of complement by liposomes.
Chonn A; Cullis PR; Devine DV
J Immunol; 1991 Jun; 146(12):4234-41. PubMed ID: 2040798
[TBL] [Abstract][Full Text] [Related]
10. Killing of the S and Re forms of Salmonella minnesota via the classical pathway of complement activation in guinea-pig and human sera.
Clas F; Loos M
Immunology; 1980 Aug; 40(4):547-56. PubMed ID: 6776034
[TBL] [Abstract][Full Text] [Related]
11. Antibody-mediated alternative complement pathway activation resists inhibition by sialoglycolipids.
Okada N; Yasuda T; Okada H
J Immunol; 1985 May; 134(5):3316-9. PubMed ID: 2580023
[TBL] [Abstract][Full Text] [Related]
12. Binding of C3 molecules to membranes via the SH-residue generated by the cleavage of a thioester bond can initiate complement activation.
Okada N; Yasuda T; Okada H
Biochem Biophys Res Commun; 1988 Mar; 151(2):743-8. PubMed ID: 3348808
[TBL] [Abstract][Full Text] [Related]
13. Assay of complement activity in human serum using large unilamellar liposomes.
Masaki T; Okada N; Yasuda R; Okada H
J Immunol Methods; 1989 Sep; 123(1):19-24. PubMed ID: 2794527
[TBL] [Abstract][Full Text] [Related]
14. Complement activating property of the protein-rich endotoxin (OEP) of Pseudomonas aeruginosa. I. Activation of both the classical and the alternative pathways of guinea pig complement.
Inada K
Jpn J Exp Med; 1980 Feb; 50(1):13-21. PubMed ID: 6770130
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of C-reactive protein on alternative C pathway activation by liposomes and Streptococcus pneumoniae.
Mold C; Gewurz H
J Immunol; 1981 Nov; 127(5):2089-92. PubMed ID: 6913608
[TBL] [Abstract][Full Text] [Related]
16. Regulation of glycophorin of complement activation via the alternative pathway.
Okada N; Yasuda T; Tsumita T; Shinomiya H; Utsumi S; Okada H
Biochem Biophys Res Commun; 1982 Sep; 108(2):770-5. PubMed ID: 7150322
[No Abstract] [Full Text] [Related]
17. Activation of human complement by liposomes: a model for membrane activation of the alternative pathway.
Cunningham CM; Kingzette M; Richards RL; Alving CR; Lint TF; Gewurz H
J Immunol; 1979 Apr; 122(4):1237-42. PubMed ID: 448089
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of the in vivo circulation lifetime of L-alpha-distearoylphosphatidylcholine liposomes: importance of liposomal aggregation versus complement opsonization.
Ahl PL; Bhatia SK; Meers P; Roberts P; Stevens R; Dause R; Perkins WR; Janoff AS
Biochim Biophys Acta; 1997 Oct; 1329(2):370-82. PubMed ID: 9371428
[TBL] [Abstract][Full Text] [Related]
19. IgG and complement-mediated tissue damage in the absence of C2: evidence of a functionally active C2-bypass pathway in a guinea pig model.
Wagner E; Platt JL; Howell DN; Marsh HC; Frank MM
J Immunol; 1999 Sep; 163(6):3549-58. PubMed ID: 10477630
[TBL] [Abstract][Full Text] [Related]
20. Effect of gangliosides on activation of the alternative pathway of human complement.
Michalek MT; Bremer EG; Mold C
J Immunol; 1988 Mar; 140(5):1581-7. PubMed ID: 3346542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
